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Phototesting and photoprotection in LE
M Walchner, G Messer and P Kind
Department of Dermatology, Ludwig-Maximilians-University of Munich, FrauenlobstraBe 9-11, D-80337 Munich, Germany
Photosensitivity and induction of skin lesions following UV radiation is a common problem of
patients with cutaneous and systemic forms of lupus erythematosus. The detrimental effect of UV
radiation to patients with lupus erythematosus was already recognized in the last century. Skin
lesions can now be provoked under standardized conditions allowing the diagnosis and
classification of patients with photosensitive disorders. The aim of this review is to give an
overview on the history, test procedure and test results in patients with lupus erythematosus.
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Introduction
Lupus erythematosus (LE) develops due to reduction
of tolerance against self. Systemic and cutaneous
forms can be distinguished according to clinical,
histological and immunologic parameters. Among
these are systemic lupus erythematosus’,’ (SLE),
subacute cutaneous lupus erythematosus’ (SCLE),
lupus erythematosus tumidus6 (LET), lupus erythe-
matosus profundus 7,8 (LEP), chronic discoid lupus
erythematosusS,9( CD LE) and disseminated discoid
lupus erythematosus.l° (DDLE). Cutaneous lesions
tend to occur in sun-exposed areas of the skin and can
be reproduced experimentally. Photosensitivity is
common in LE patients. Our own investigations on
189 patients revealed that almost every second patient
with systemic or generalized forms of LE (SLE: 48%;
SCLE: 49%, DDLE: 45%, LET: 43%) and approxi-
mately every forth patient with cutaneous disease
(DLE: 25%) reported photosensitivity. Phototesting
with standardized protocols, however, demonstrated
that these percentages differ’ 1,12 (SLE: 35%, SCLE:
63%, LET: 81 %, DLE: 36%). One of the reasons for
the divergent data between the reported and tested
photosensitivity may be the fact that skin lesions
following UV radiation do not develop rapidly after a
few hours like sunburn reaction, but appear after two
to three weeks. Therefore, a relationship between sun
exposure and exacerbation of LE does not seem
obvious to the patient.
UV-induced skin damage in general depends on the
quality and quantity of UV radiation. Photons,
packages of energy, have a defined energy depending
on the wavelength and frequency. The energy of a
photon is inversely related to the wavelength and
directly related to the frequency. When light meets the
outer surface of the skin it is partially reflected
depending on the surface. The absorbed part of the
light energy reaches deeper layers. The penetration
depends on the refractive index of each tissue. Almost
all of the UVB radiation is absorbed in the first 0.3 mm
of normal skin, whereas practically all of visible light
penetrates into the subcutis. Generally said, the longer
the wavelength the deeper the penetration. This is
partly due to absorption of higher light energy by
chromophores contained in the outer layers.
The first step of a photoinduced skin reaction is the
absorption of photons by chromophores leading to the
formation of photoproducts. Cells of the dermis,
epidermis, and subcutis contain chromophores such as
DNA, RNA, proteins, porphyrins and lipids. DNA is
mainly affected by electromagnetic waves between
250 and 300 nm, since the absorption spectra of
pyrimidines and purines are within these wave-
lengths. 13 Proteins contain cyclic molecules such as
aromatic (tyrosine, phenylalanine) and heterocyclic
(tryptophane, histidine) amino acids. After activation
by UV rays chromophores become unstable and by
releasing energy return back to their original energy
stage. Energy is then transferred to secondary
molecules and formation of reactive oxygen inter-
mediates (ROI) follows.&dquo; These molecules are central
mediators of cell activation leading to gene expression
and synthesis of proteins, such as pro-inflammatory
cytokines. 15 Concerning lupus erythematosus it was
shown that UVA and UVB irradiation induces
stronger accumulation of ROI in murine SLE-derived
spleen cells compared to controls. 16
After the initiation several steps follow, in general
leading to upregulation of cell membrane proteins,
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translocation of intracellular proteins, apoptosis,
disappearance of Langerhans cells and formation of
inflammatory infiltrates. Cytokines released by kera-
tinocytes are important mediators of skin reactions
following UV radiation.&dquo;-19 One of these cytokines
dominant in contact hypersensitivity and UV-induced
skin reactions is tumor necrosis factor (TNF)-a. The
TNF-a and 
-~3 promoters contain UV-responsive
elements, for example recognition sequences binding
the nuclear factor (NF)-kB, which is indirectly
activated by ROI.I5,20,21 Genetic polymorphisms may
furthermore predispose to enhanced photosensitivity,
for example a promoter/enhancer polymorphism of
TNF-a is significantly associated with enhanced TNF-
secretion levels upon stimulation (Mayer et al,
personal communication) and with photosensitivity
in SCLE patients (Schmidt et al, personal commu-
nication). Other cytokines like IL-1, IL-3 and TGF-~3
are also important mediators of inflammatory skin
reactions.22°23 Once generated, binding of autoantibo-
dies against structures on the celluar surface may then
lead to antibody dependent cell cytotoxicity and
destruction.2¢2’ Histologically basement membrane
thickening, deposition of immunoglobulins and
complement factors, atrophy of the pilosebaceous
apparatus, lymphocytic infiltrates, hyperkeratosis and
epidermal cell necrosis can be found to varying
degrees in cutaneous and systemic forms of Lye. 1133
It is generally accepted that photodamage in CDLE
patients is restricted to local tissue and not observed in
sun-protected areas, whereas this restriction is not the
case in SLE patients. Here, even exacerbation of
systemic disease may follow UV radiation. In various
mouse models with increased susceptibility for the
development of SLE-like disease it was shown that
mainly UVB radiation in vivo caused increased
mortality and accelerated the development of auto-
immune responses.34,35 The data concerning UVA
radiation, however, are still controversial. 36 In an
attempt to standardize conditions leading to photo-
induced skin lesions phototests were established.
History
In 1851 Cazenave suggested the term ’lupus erythe-
matosus’ (LE) for a disease characterized by red spots
and thinning of the skin on cheeks and ears with a
chronic course. He observed that it could spread to the
body and appeared in most patients without harm to
general health.3’ Cold air or fire were suspected
trigger factors. Despite an excellent description of
systemic and cutaneous forms of LE Kaposi supposed
factors like local seborrhea and hormones, but not UV
radiation, leading to an inflammation of the sebaceous
glands.38 Only some years later a possible role of the
sunlight in development of LE was recognized.39
Several publications followed demonstrating the
effect of sunlight on LE and the increased incidence
in the months of spring.4O--42 These observations led to
the conclusion that LE belongs to the group of
photoaggravated diseases ’occuring as Koebner phe-
nomenon’ .43
The first intended photoprovocation of two LE
patients was probably performed by Jesionek pub-
lished in the ’modem guide lines of light therapy’ in
Table 1 Phototesting in LE
*Clinical data resemble SCLE [4].
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1916~ (Table 1). He claimed to be able to reproduce
skin lesions by the use of light. Years later Davidson
observed development of skin lesions in a LE patient
following UV radiation with a quartz lamp for the
treatment of tuberculosis and noted the beneficial
effect of oral administration of quinine in the
treatment of LE.45 A decade later Zarafonetes
observed five out of eight patients who were
hypersensitive to tests with ultraviolet light.46 In this
series he also noted a favorable protection of para-
aminobenzoate as a form of chemical sunscreen. Also
Garzon et al47 was able to reproduce skin lesions in a
patient with subacute lupus erythematosus, probably a
patient with SCLE. In parallel he demonstrated the
beneficial effect of sunscreens.
Early clinial studies for testing photosensitivity of
LE patients were performed by the groups of
Epstein,48 Baer49 Everett5° and Freeman.51 Already
then the results were controversial. Using a hot quartz
contact lamp as UVB source Epstein et al tested 25
patients (21 SLE; 4 DLE). Nine patients had a history
of photosensitivity and of these five developed local
erythema persisting up to three months. Biopsies
taken between two and six months after phototesting
revealed hyperkeratosis, epidermal atrophy and cell
destruction. Although not discussed in the paper, it is
interesting that the follow-up of these patients must
have been several weeks. It is now known that LE skin
lesions typically occur after two to three weeks. In the
report no reactions were noticed with wavelengths
longer than 320 nm. Baer and Harber noted that UVB
radiation may cause systemic exacerbation in patients
with subacute LE. They tested 29 patients (23 x DLE;
5 x SLE; 1 x subacute LE) using a bank of four
fluorescent sunlamps having a continuous emission
spectrum between 280 and 320 nm. No differences of
the erythema response compared to controls were
noted. Only the patient with subacute LE developed a
markedly decreased erythema threshold followed by
persistent erythema. From these results they con-
cluded that UV radiation is a trigger factor in a small
number of LE patients, furthermore, it may induce
systemic disease. One of the reasons for the lack of
positive test results may be the fact that they only
studied patients after 24 h and one week, thereby
possibly missing the skin lesions appearing after two
to three weeks. In another test series Freeman et a151
found that 8/10 DLE patients have positive reactions
at 300 nm, but none of five LE patients taking
quinacrine could be provoked. No reactions were
observed using the wavelengths 340, 360, 400 or
500 nm. However, again here problems arise concern-
ing interpretation of data, since different energy doses
were applied and higher energy doses of UVA than
UVB are normally needed to induce photobiologically
relevant reactions. Other investigations with the aim
of finding the relevant wavelength for the induction of
LE skin lesions were undertaken by Cripps and
Rankin52 in vivo and Emerit and Michelson in vitro.53
Cripps and Rankin observed that long-lasting erythe-
ma could be induced in LE patients by radiation with
a range from 250 to 330 nm, but not wavelengths
higher than that. Emerit and Michelson detected that
lymphocytes derived from SLE patients were sensi-
tive to UVA radiation (360 to 400 nm) in vitro.
In an attempt to use in vivo photosensitivity tests to
investigate the action of drugs Lester et al studied the
role of hydroxychloroquine sulfate, methylpredniso-
lone sodium succinate and methotrexate in blocking
light induced skin reactions.54 They tested 64 patients
with various photosensitive disorders such as poly-
morphic light eruption (29 patients), systemic (5
patients) and cutaneous LE (9 patients). Totally 21/29,
4/5 and 4/9 showed photoprovocation. In a group of
selected patients they found that intradermally applied
hydroxychloroquine blocked the reaction in five of
seven patients. They discussed a possible association
of positive antinuclear antibodies and positive test
reaction. Moreover, Gilliam and Sontheimer were
able to describe a separate form of LE, the subacute
cutaneous LE (SCLE), a very photosensitive disease,
differing from SLE and DLE and associated with the
presence of anti-Ro antibodies.4 These antibodies later
attracted much interest. It was observed that Ro
antigens were expressed on the surface of keratino-
cytes following UV radiation, thereby possibly
provoking antibody dependent cell cytotoxicity. 55
The group of Rosen showed elegantly in their study
that these antigens were expressed during a process
called apoptosis.56,57
Phototest procedure
Phototesting is a tool for diagnosis, documentation,
identification of photosensitizers (photopatch test),
therapy and investigation of pathophysiologically
relevant factors. It should be carried out in patients
with suspected hypersensitivity to light, for example
solar urticaria, polymorphic light eruption, photo-
allergy, phototoxicity, lupus erythematosus or other
autoimmune disorders. 58
As a light source monochromatic light, metal halide
lamps or a source equipped with fluorescent bulbs can
be applied. Usually UVB and UVA radiation is used
for testing photosensitivity of LE patients, however,
certain photosensitive disorders such as solar urticaria
may also require testing with visible light. Since
sensitivity to UV radiation differs, testing the minimal
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erythema dose (MED) is necessary to make data
comparable. The MED is defined as the minimal
erythema occuring at a certain dose of UV radiation,
usually UVB.59 MED depends on the wavelength and
individual skin sensitivity. As a general rule, the lower
the wavelength the lower the amount of energy doses
necessary for the induction of one MED. The mean
MED is 0. 1 ( f 0.03) J/cm2 at 300 nm.6° UVB has the
highest relative effectiveness in the induction of
erythema and late tanning after 12-24 h. Also UVA
may provoke erythema after 1-2 h with a maximum
around 6-12 h, however, 500-1000 times higher doses
are necessary compared to UVB. Physiologically, this
is compensated by the fact that sun light, for example
in Europe, contains nine times more UVA than UVB
radiation. UVA causes immediate pigment darkening
(IPD) depending on the dose (5-20 j/CM2 at 320-
340 nm), probably by induction of oxidative pro-
cesses. It also induces de novo synthesis of pigment
after 1 ~20 h. The dose for IPD is 19 (±4.6) J/cm2.6o
Combination of UVA and UVB causes photoaugmen-
tation and persistent pigmentation.
Usually the non-sunexposed, not affected areas of
the back or the lower arms are used for phototesting in
LE patients.l2 Other parts of the skin may not react to
the same extent probably due to thickness of the
epidermal horny layers, vascularization, presence of
antigen and distribution of antigen-presenting
cells.l2°6’ For standardization it is important to use a
defined test area. The size of this should be
sufficiently large to provide reactions. As a recom-
mendation it should cover 5 x 8 cm2.12,60 For the
performance of the phototest we use 100 J/cm2 UVA
and 1.5 MED UVB on three following days. Single
exposure to UV radiation may not induce positive
reaction in all possible cases. The evaluation follows
after 24 h, 48 h, 72 h as well as weekly until three or
more weeks. Criteria for a positive photoprovocation
are: (1) skin lesions resemble clinically LE, (2) slow
development of skin lesions over several days or
weeks and (3) confirmation of clinical diagnosis by
histology. Typically, development of LE skin lesions
has a latency of two weeks and may persist for
months. Provocation of systemic disease in patients
with SLE as a result of phototesting has not been
observed. However, patients should be reminded of
the fact that both hyperpigmentation, hypopigmenta-
tion and LE skin lesions may follow and persist for
months leading to cosmetic problems.
Results of phototests
Results of reported photosensitivity in patients with
cutaneous and systemic forms of LE often differ
between various groups (Table 2). Several factors are
responsible, for example definition of photosensitivity
by the investigator, form of questioning, genetic
background of the studied population and environ-
mental factors. An additional factor might be the age
at onset of disease and subjective photosensitivity as
observed in our study of 189 LE patients (Table 3).
Mainly patients under the age of 40 years reported
photosensitivity.
In an attempt to standardize photosensitive dis-
orders phototesting procedures were elaborated.
Lehmann et al investigated MED and IPD in LE
patients, since activation of skin lesions may be due to
an enhanced response already to lower doses of UV
radiation, however, no differences of MED or IPD
were found.6° Positive reactions after phototesting
were observed to varying percentages in LE patients
with cutaneous and systemic forms in our study
(Table 4). Most of the patients with positive test
results were provoked by UVB radiation. UVA
induction of skin lesions was only found in patients
with SCLE, SLE or LET. Also here, differences were
Table 2 Reported photosensitivity
Table 3 Photosensitivity and age at disease onset
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Figure 1 Comparison of phototest results. Patients with DLE (n = 28), SCLE (n = 20) SLE (n = 20) were tested according to the protocol by Lehmann et
al.6O Positive and negative results were correlated with anti-Ro antibodies.
found due to the age of the patient at onset of disease
(Table 3). Further investigations of immunologic
parameters in phototested patients point to an
association of positive phototest results and the
finding of Ro antibodies (Figure 1). Therefore
phototesting may help to subclassify patients in order
to find genetic and immunologic factors associated
with photosensitivity in the future. Genetic variance of
the TNF genes and of putative genetic differences in
the UV-stress response (NF-kB) represent good
candidates.
Unfortunately test protocols vary between different
groups making comparison of test results often
difficult (Table 1). Varying factors are the light source
used, the energy dose, wavelength, development of
heat during radiation, time points of provocation and
evaluation, location and size of test area. Furthermore,
classification of positive reactions may be difficult,
since persistent erythema may develop, which despite
histological investigation is difficult to interpret.
Kind and coworkers could demonstrate that the
histopathology of early UV-induced lesions (up to
ten days) in patients with cutaneous and systemic
forms of LE shows unspecific changes such as
superficial perivascular lymphocytic infiltrates,
whereas late UV-induced lesions (more than ten days)
were characterized by parakeratosis, few necrotic
basal keratinocytes as well as vacuolar degeneration
of the dermoepidermal zone.&dquo; Immunohistochemistry
of early lesions revealed no significantly altered
expression of HLA-DR molecules, CD8’ and CD4+
T-cells, whereas the infiltrate of late UV-induced
lesions mainly consisted of CD4+ T-cells in DLE and
CD8’ T-cells in SCLE.12 It is so far unclear, why skin
lesions cannot always be reproduced at the same test
area.62 An intriguing point is also the question why
phototesting is not positive in 100% of LE patients,
thus providing indirect evidence for variant para-
meters in the pathophysiology of LE and a variant
threshold of inducibility.
Photoprotection
Tanning is fashionable,63 however, besides photoage-
ing UV radiation is a trigger factor for LE.
Consequent protection against UV radiation is there-
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fore necessary. In principal two possibilities exist,
topical or systemic protection
Topical protection against UV rays can be achieved
by avoiding sun light and using sunblockers. Hat,
clothes, umbrella and other physical factors provide
only limited protection against UV radiation. Also the
general belief that clouds hinder UV radiation from
reaching the earth is wrong and tempts patients to stay
out longer.66 Window glass only blocks UVB, but not
UVA radiation and surfaces of sand and water may
reflect sun rays thereby intensifying direct and indirect
UV radiation. Therefore, physical protection cannot
be sufficient in the photoprotection of LE patients.
Sunblockers or sunscreens are topically used
preparations that reduce local UV action. These can
be subdivided into products using UV filters on a
physical or on a chemical background. Examples for
physical sunblocking agents are titanium dioxide,
talcum or zinc oxide (UVB and UVA), and for
chemical photoprotective products para-amino-ben-
zoic acid (PABA) derivatives and benzophenones.64,65
Most chemical sunblockers contain a combination of
different filters in order to block a higher percentage
and broader range of UV rays.
Physical suncreens do not absorb UV rays, but
rather reflect or disperse,6’ serving as shield against
UVA and UVB radiation. Usually they are non-
photosensitizing, but may sometimes be unacceptable
for patients, since they are partially visible. Further-
more, physical sunscreens are normally not easily
washed off, moreover, offer limited protection over
time, since they melt with the heat of the sun.
Chemical sunblocking agents consist of chemical
light-absorbing molecules, they are efficient in block-
ing UVB and shorter UVA rays. One of the first sun-
protective chemicals was benzyl cinnamate and
benzyl salicylate, later followed by para-amino-
benzoic acid (PABA) and esters, benzophenones and
ethylhexyl-para-methoxy cinnamate.64,67 Chemical
sunblockers penetrate into the stratum comeum, stay
attached to proteins and therefore are not easily
washed off.64,65 On the other hand, chemical sun-
blockers have a higher risk for the development of
photoallergic or phototoxic reactions. 58,68
Effectiveness of sunblockers is expressed as the
sun/ultraviolet protection factor (SPF/UPF), which is
defined as the ratio of the MED of sun-protected skin
divided by the MED of non-sunprotected skin. Filters
with SPF of 15 protect from more than 90% of UV
radiation. The protection against longer UVA waves
may not be properly fulfilled. Furthermore, individual
factors such as sweating, skin thickness and applica-
tion of the product may lead to differences.64
Photoprotection may also be achieved by systemic
medication with drugs such as chloroquine, hydroxy-
chloroquine, vitamins (C and E) and retinoids. Their
exact mode of action is still unknown, however, they
may act as antioxidants, thereby interacting with the
formation of ROI, block local and systemic immune
reactions and indirectly hinder UV radiation from
induction of skin lesions.64,69--72
Conclusions
Standardized phototest procedures are available for
the diagnosis and classification of photosensitive
disorders. Phototesting is a valid model for the
identification of relevant pathogenetic factors in the
development of lupus erythematosus. Further experi-
mental studies are necessary to elucidate these factors
molecularly.
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